M. B. Hayagrivas
YOU?
Author Swipe
View article: Clinical Utility of Assessing CDKN2A Status in Recurrent Astrocytomas
Clinical Utility of Assessing CDKN2A Status in Recurrent Astrocytomas Open
Background: IDH-mutant astrocytomas exhibit a more indolent natural history and better prognosis compared to their IDH-wild type counterparts. The 2021 WHO classification integrated CDKN2A/Bhomozygous deletion as a crucial criterion for gr…